Artigo Revisado por pares

Analysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC

2023; Elsevier BV; Volume: 78; Linguagem: Inglês

10.1016/s0168-8278(23)01039-5

ISSN

1600-0641

Autores

Alexander Miethke, Adib Moukarzel, Gilda Porta, Joshue Covarrubias Esquer, Piotr Czubkowski, Felipe Ordoñez, M. Candusso, Amal Aqul, Robert H. Squires, Étienne Sokal, Daniel D’Agostino, Ulrich Baumann, Lorenzo D’Antiga, Nagraj Kasi, Nolwenn Laborde, Çiğdem Arıkan, Chuan-Hao Lin, Susan Gilmour, Naveen Mittal, Fang Kuan Chiou, Simon Horslen, Wolf‐Dietrich Huber, Susan David-Feliciano, Elaine Chien, Douglas Mogul, Will Garner, Tiago Nunes, Anamaria Lascau, Pamela Vig, Vera Hupertz, Regino P. González‐Peralta, Udeme D. Ekong, Jane Hartley, Noémie Laverdure, Nadia Ovchinsky, Richard Thompson,

Tópico(s)

Hepatitis B Virus Studies

Referência(s)
Altmetric
PlumX